Statistical Model for Prediction of Hearing Loss in Patients Receiving Cisplatin Chemotherapy (vol 139, pg 256, 2013)

被引：0
|
作者：
Johnson, Andrew
机构：
来源：
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY | 2013年 / 139卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
引用
收藏
页码：1078 / 1078
页数：1
相关论文
共 50 条
  • [1] Statistical Model for Prediction of Hearing Loss in Patients Receiving Cisplatin Chemotherapy
    Johnson, Andrew
    Tarima, Sergey
    Wong, Stuart
    Friedland, David R.
    Runge, Christina L.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2013, 139 (03) : 256 - 264
  • [2] Prevention of Hearing Loss in Children Receiving Cisplatin Chemotherapy
    Freyer, David R.
    Sung, Lillian
    Reaman, Gregory H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (02) : 317 - 318
  • [3] HEARING-LOSS IN CHILDREN RECEIVING CISPLATIN CHEMOTHERAPY
    MCHANEY, VA
    THIBADOUX, G
    HAYES, FA
    GREEN, AA
    JOURNAL OF PEDIATRICS, 1983, 102 (02): : 314 - 317
  • [4] Prevention of Hearing Loss in Children Receiving Cisplatin Chemotherapy REPLY
    Fouladi, Maryam
    Gajjar, Amar
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (02) : 318 - 319
  • [5] Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy (vol 41, pg 1345, 2009)
    Ross, Colin J. D.
    Katzov-Eckert, Hagit
    Dube, Marie-Pierre
    Brooks, Beth
    Rassekh, S. Rod
    Barhdadi, Amina
    Feroz-Zada, Yassamin
    Visscher, Henk
    Brown, Andrew M. K.
    Rieder, Michael J.
    Rogers, Paul C.
    Phillips, Michael S.
    Carleton, Bruce C.
    Hayden, Michael R.
    NATURE GENETICS, 2013, 45 (05) : 578 - 578
  • [6] Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
    Colin J D Ross
    Hagit Katzov-Eckert
    Marie-Pierre Dubé
    Beth Brooks
    S Rod Rassekh
    Amina Barhdadi
    Yassamin Feroz-Zada
    Henk Visscher
    Andrew M K Brown
    Michael J Rieder
    Paul C Rogers
    Michael S Phillips
    Bruce C Carleton
    Michael R Hayden
    Nature Genetics, 2009, 41 : 1345 - 1349
  • [7] Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
    Ross, Colin J. D.
    Katzov-Eckert, Hagit
    Dube, Marie-Pierre
    Brooks, Beth
    Rassekh, S. Rod
    Barhdadi, Amina
    Feroz-Zada, Yassamin
    Visscher, Henk
    Brown, Andrew M. K.
    Rieder, Michael J.
    Rogers, Paul C.
    Phillips, Michael S.
    Carleton, Bruce C.
    Hayden, Michael R.
    NATURE GENETICS, 2009, 41 (12) : 1345 - U118
  • [8] Hearing Loss Risk in Pediatric Patients Treated with Cranial Irradiation and Cisplatin-Based Chemotherapy (vol 110, pg 1488, 2021)
    Cohen-Cutler, Sally
    Wong, Kenneth
    Mena, Victoria
    Sianto, Kevin
    Wright, Michael A.
    Olch, Arthur
    Orgel, Etan
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (03): : 838 - 839
  • [9] Erratum: Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
    Colin J D Ross
    Hagit Katzov-Eckert
    Marie-Pierre Dubé
    Beth Brooks
    S Rod Rassekh
    Amina Barhdadi
    Yassamin Feroz-Zada
    Henk Visscher
    Andrew M K Brown
    Michael J Rieder
    Paul C Rogers
    Michael S Phillips
    Bruce C Carleton
    Michael R Hayden
    Nature Genetics, 2013, 45 : 578 - 578
  • [10] Validation of Hearing Loss Prediction Tool for Cisplatin Chemotherapy and Radiation in Head and Neck Cancer Treatment
    Deutsch, Brian C.
    Collopy, Cathryn
    Kallogjeri, Dorina
    Piccirillo, Jay F.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2021, 147 (02) : 182 - 189
12345